identified the role of FoxP3 in tumor malignancy, as the downregulation of FoxP3 inhibits proliferation, invasiveness, and metastasis of tumor cells, reduces IL-10 and TGF-β signaling, and blocks immune escape in CCA (91). This evidence concerns the gene IL10 and cholangiocarcinoma.